Wollenhaupt J, Silverfield J, Bong Lee E, et al. Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 9 Years. ACR 2017, abstract 522.
Vaccineren tijdens actieve reumatische ziekte?
sep 2023 | RA, SLE, Vaccinatie, Virale infecties